logo

6550--Notice Of Intent To Sole-Source T-Spot.Tbâ® Reagents And Kits

Sector: Manufacturing (Industrial) • Location: United States of America

Source: SAMGOVCO

Tender
Special Notice

This notice is being published in accordance with Revolutionary FAR Overhaul Federal Acquisition Regulation (RFO FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions. The Department of Veterans Affairs, Network Contracting Office (NCO) 2, hereby provides notice of its intent to award a sole source, firm fixed price contract to Euroimmun US Incorporated, the sole

Status
Prospective
Sector
Manufacturing (Industrial), Commercial, Residential, Hospital
Location
United States of America
Updated
3 Nov 2026
Source
SAMGOVCO

ConstructChat

Ask ConstructChat about 6550--Notice Of Intent To Sole-Source T-Spot.Tbâ® Reagents And Kits

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Tender Information FAQ

Tender Information

3 Q
The tender “6550--Notice Of Intent To Sole-Source T-Spot.Tbâ® Reagents And Kits” is a tender record in Taiyo, linked to the Manufacturing (Industrial) sector. It is issued for works, goods, or services related to United States of America.

Participants

Not available for this record.

Status

Original status

special notice

Taiyo status

Prospective

Taiyo last update

2026-11-03

Contact

Not available for this record.

Description

Description

This notice is being published in accordance with Revolutionary FAR Overhaul Federal Acquisition Regulation (RFO FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions. The Department of Veterans Affairs, Network Contracting Office (NCO) 2, hereby provides notice of its intent to award a sole source, firm fixed price contract to Euroimmun US Incorporated, the sole authorized U.S. distributor of T SPOT.TB® reagents and associated kits manufactured by Oxford Immunotec. These reagents are required for tuberculosis testing at VA Western New York Healthcare System (VAWNYHS) Buffalo VA Medical Center (VAMC). This determination is made in accordance with RFO FAR 12.201-1, Only one responsible source and no other supplies or services will satisfy agency requirements. The T SPOT.TB® assay is a patented IGRA platform, and its reagents including the antigen panels, controls, and AIM V media are proprietary and FDA cleared only for use with the OEM platform. Oxford Immunotec holds the exclusive patent rights, and Euroimmun US Incorporated is the only supplier legally authorized to provide these FDA approved reagents for federal healthcare facilities. No other vendor can supply reagents that meet FDA, CLIA, CAP, and Joint Commission requirements. This notice is not a request for competitive quotes. However, interested parties may identify their interest and capability to respond to this requirement by submitting a: Capability Statement (1 page maximum) Company Name UEI Number Socioeconomic Status Proof of authorization to provide the OEM reagents Responses must be received no later than 4:00 PM EST on October 16, 2026 to Myra.Green2@va.gov A determination not to compete this proposed action is solely within the discretion of the Government. Information received will only be considered for determining whether to conduct a competitive procurement in the future. Prospective contractors must be registered in SAM.gov to be eligible for award.

Original sector

Not Identified

Location

Country

United States of America (USA)

Source

Source

SAMGOVCO

URL

More Details

Record type

Tender

Sector

Manufacturing (Industrial), Commercial, Residential, Hospital

Article published date

2026-10-03

More on this tender

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this tender
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this tender